{
  "ticker": "LH",
  "last_updated": "2025-04-19T09:10:58.394959",
  "retention_years": 3,
  "count": 754,
  "transactions": [
    {
      "id": 243589,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2025-01-07",
      "transaction_shares": "1000",
      "transaction_price": "235.00",
      "transaction_type": "S",
      "shares_after_transaction": "12722"
    },
    {
      "id": 209458,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2024-12-02",
      "transaction_shares": "1000",
      "transaction_price": "241.00",
      "transaction_type": "S",
      "shares_after_transaction": "7712"
    },
    {
      "id": 209470,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Executive Vice President",
      "transaction_date": "2024-12-02",
      "transaction_shares": "8923",
      "transaction_price": "209.25",
      "transaction_type": "M",
      "shares_after_transaction": "40212"
    },
    {
      "id": 243575,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2024-12-02",
      "transaction_shares": "1000",
      "transaction_price": "241.00",
      "transaction_type": "S",
      "shares_after_transaction": "7712"
    },
    {
      "id": 243587,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Executive Vice President",
      "transaction_date": "2024-12-02",
      "transaction_shares": "8923",
      "transaction_price": "209.25",
      "transaction_type": "M",
      "shares_after_transaction": "40212"
    },
    {
      "id": 177904,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-11-22",
      "transaction_shares": "4015",
      "transaction_price": "168.52",
      "transaction_type": "M",
      "shares_after_transaction": "7990"
    },
    {
      "id": 209482,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-11-22",
      "transaction_shares": "4015",
      "transaction_price": "168.52",
      "transaction_type": "M",
      "shares_after_transaction": "7990"
    },
    {
      "id": 243600,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-11-22",
      "transaction_shares": "4015",
      "transaction_price": "168.52",
      "transaction_type": "M",
      "shares_after_transaction": "7990"
    },
    {
      "id": 177896,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-11-21",
      "transaction_shares": "1000",
      "transaction_price": "239.4187",
      "transaction_type": "S",
      "shares_after_transaction": "2669.847"
    },
    {
      "id": 209474,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-11-21",
      "transaction_shares": "1000",
      "transaction_price": "239.4187",
      "transaction_type": "S",
      "shares_after_transaction": "2669.847"
    },
    {
      "id": 243592,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-11-21",
      "transaction_shares": "1000",
      "transaction_price": "239.4187",
      "transaction_type": "S",
      "shares_after_transaction": "2669.847"
    },
    {
      "id": 177851,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-11-11",
      "transaction_shares": "6189",
      "transaction_price": "243.47",
      "transaction_type": "S",
      "shares_after_transaction": "87441"
    },
    {
      "id": 209426,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-11-11",
      "transaction_shares": "6189",
      "transaction_price": "243.47",
      "transaction_type": "S",
      "shares_after_transaction": "87441"
    },
    {
      "id": 243543,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-11-11",
      "transaction_shares": "6189",
      "transaction_price": "243.47",
      "transaction_type": "S",
      "shares_after_transaction": "87441"
    },
    {
      "id": 148760,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-10-24",
      "transaction_shares": "1000",
      "transaction_price": "230.00",
      "transaction_type": "S",
      "shares_after_transaction": "13722"
    },
    {
      "id": 177860,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-10-24",
      "transaction_shares": "1000",
      "transaction_price": "230.00",
      "transaction_type": "S",
      "shares_after_transaction": "13722"
    },
    {
      "id": 209436,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-10-24",
      "transaction_shares": "1000",
      "transaction_price": "230.00",
      "transaction_type": "S",
      "shares_after_transaction": "13722"
    },
    {
      "id": 243553,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-10-24",
      "transaction_shares": "1000",
      "transaction_price": "230.00",
      "transaction_type": "S",
      "shares_after_transaction": "13722"
    },
    {
      "id": 96761,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-08-19",
      "transaction_shares": "2000",
      "transaction_price": "227.05",
      "transaction_type": "S",
      "shares_after_transaction": "3669.847"
    },
    {
      "id": 121770,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-08-19",
      "transaction_shares": "2000",
      "transaction_price": "227.05",
      "transaction_type": "S",
      "shares_after_transaction": "3669.847"
    },
    {
      "id": 148756,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-08-19",
      "transaction_shares": "2000",
      "transaction_price": "227.05",
      "transaction_type": "S",
      "shares_after_transaction": "3669.847"
    },
    {
      "id": 177856,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-08-19",
      "transaction_shares": "2000",
      "transaction_price": "227.05",
      "transaction_type": "S",
      "shares_after_transaction": "3669.847"
    },
    {
      "id": 209432,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-08-19",
      "transaction_shares": "2000",
      "transaction_price": "227.05",
      "transaction_type": "S",
      "shares_after_transaction": "3669.847"
    },
    {
      "id": 243549,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-08-19",
      "transaction_shares": "2000",
      "transaction_price": "227.05",
      "transaction_type": "S",
      "shares_after_transaction": "3669.847"
    },
    {
      "id": 96751,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-08-15",
      "transaction_shares": "2979",
      "transaction_price": "222.6494",
      "transaction_type": "S",
      "shares_after_transaction": "43310"
    },
    {
      "id": 121760,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-08-15",
      "transaction_shares": "2979",
      "transaction_price": "222.6494",
      "transaction_type": "S",
      "shares_after_transaction": "43310"
    },
    {
      "id": 148746,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-08-15",
      "transaction_shares": "2979",
      "transaction_price": "222.6494",
      "transaction_type": "S",
      "shares_after_transaction": "43310"
    },
    {
      "id": 177845,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-08-15",
      "transaction_shares": "2979",
      "transaction_price": "222.6494",
      "transaction_type": "S",
      "shares_after_transaction": "43310"
    },
    {
      "id": 209420,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-08-15",
      "transaction_shares": "2979",
      "transaction_price": "222.6494",
      "transaction_type": "S",
      "shares_after_transaction": "43310"
    },
    {
      "id": 243537,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-08-15",
      "transaction_shares": "2979",
      "transaction_price": "222.6494",
      "transaction_type": "S",
      "shares_after_transaction": "43310"
    },
    {
      "id": 96794,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-07",
      "transaction_shares": "414",
      "transaction_price": "225.00",
      "transaction_type": "S",
      "shares_after_transaction": "15308"
    },
    {
      "id": 121803,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-07",
      "transaction_shares": "414",
      "transaction_price": "225.00",
      "transaction_type": "S",
      "shares_after_transaction": "15308"
    },
    {
      "id": 148790,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-07",
      "transaction_shares": "414",
      "transaction_price": "225.00",
      "transaction_type": "S",
      "shares_after_transaction": "15308"
    },
    {
      "id": 177892,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-07",
      "transaction_shares": "414",
      "transaction_price": "225.00",
      "transaction_type": "S",
      "shares_after_transaction": "15308"
    },
    {
      "id": 209469,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-07",
      "transaction_shares": "414",
      "transaction_price": "225.00",
      "transaction_type": "S",
      "shares_after_transaction": "15308"
    },
    {
      "id": 243586,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-07",
      "transaction_shares": "414",
      "transaction_price": "225.00",
      "transaction_type": "S",
      "shares_after_transaction": "15308"
    },
    {
      "id": 96789,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-08-05",
      "transaction_shares": "2245",
      "transaction_price": "229.785",
      "transaction_type": "S",
      "shares_after_transaction": "25769"
    },
    {
      "id": 121798,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-08-05",
      "transaction_shares": "2245",
      "transaction_price": "229.785",
      "transaction_type": "S",
      "shares_after_transaction": "25769"
    },
    {
      "id": 148785,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-08-05",
      "transaction_shares": "2245",
      "transaction_price": "229.785",
      "transaction_type": "S",
      "shares_after_transaction": "25769"
    },
    {
      "id": 177887,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-08-05",
      "transaction_shares": "2245",
      "transaction_price": "229.785",
      "transaction_type": "S",
      "shares_after_transaction": "25769"
    },
    {
      "id": 209464,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-08-05",
      "transaction_shares": "2245",
      "transaction_price": "229.785",
      "transaction_type": "S",
      "shares_after_transaction": "25769"
    },
    {
      "id": 243581,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-08-05",
      "transaction_shares": "2245",
      "transaction_price": "229.785",
      "transaction_type": "S",
      "shares_after_transaction": "25769"
    },
    {
      "id": 53206,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 73955,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 96801,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 121810,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 148797,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 177900,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 209478,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 243596,
      "issuer_name": "LABCORP HOLDINGS INC.",
      "reporting_owner": "Rothman Paul",
      "reporting_owner_cik": "0001601332",
      "reporting_owner_position": null,
      "transaction_date": "2024-06-06",
      "transaction_shares": "717",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "717"
    },
    {
      "id": 34953,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 53207,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 73956,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 96802,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 121811,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 148798,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 177901,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 209479,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 243597,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-05-14",
      "transaction_shares": "1800",
      "transaction_price": "210.8268",
      "transaction_type": "S",
      "shares_after_transaction": "5836.979"
    },
    {
      "id": 34908,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 34939,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 53161,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 53192,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 73910,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 73941,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 96753,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 96785,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 121762,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 121794,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 148748,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 148781,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 177847,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 177883,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 209422,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 209460,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 243539,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-30",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "50785"
    },
    {
      "id": 243577,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-30",
      "transaction_shares": "250",
      "transaction_price": "204.135",
      "transaction_type": "S",
      "shares_after_transaction": "15972"
    },
    {
      "id": 34924,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 53177,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 73926,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 96770,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 121779,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 148766,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 177868,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 209444,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 243561,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-04-29",
      "transaction_shares": "2439",
      "transaction_price": "204.329",
      "transaction_type": "S",
      "shares_after_transaction": "2087.2194"
    },
    {
      "id": 20319,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 34911,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 53164,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 73913,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 96756,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 121765,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 148751,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 177850,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 209425,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 243542,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-04-15",
      "transaction_shares": "10229",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "45052"
    },
    {
      "id": 20307,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 20321,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 20346,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 34898,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 34913,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 34940,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 53151,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 53166,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 53193,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 73900,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 73915,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 73942,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 96742,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 96758,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 96786,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 121751,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 121767,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 121795,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 148737,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 148753,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 148782,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 177836,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 177853,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 177884,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 209411,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 209429,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 209461,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 243528,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "205",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "505"
    },
    {
      "id": 243546,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-04-01",
      "transaction_shares": "6477",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "5036.1426"
    },
    {
      "id": 243578,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "3500",
      "transaction_price": "217.29",
      "transaction_type": "S",
      "shares_after_transaction": "3975"
    },
    {
      "id": 20337,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "6158",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13794.979"
    },
    {
      "id": 20340,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "72435",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "125429"
    },
    {
      "id": 20341,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3079",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5420.2194"
    },
    {
      "id": 20343,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "7697",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31313"
    },
    {
      "id": 20350,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-03-27",
      "transaction_shares": "20033",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43628"
    },
    {
      "id": 20354,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3012",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "6412.5491"
    },
    {
      "id": 20356,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "32942.0428"
    },
    {
      "id": 20358,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16592.1426"
    },
    {
      "id": 20360,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "5778",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "9637"
    },
    {
      "id": 34930,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "6158",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13794.979"
    },
    {
      "id": 34933,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "72435",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "125429"
    },
    {
      "id": 34934,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3079",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5420.2194"
    },
    {
      "id": 34936,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "7697",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31313"
    },
    {
      "id": 34944,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-03-27",
      "transaction_shares": "20033",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43628"
    },
    {
      "id": 34948,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3012",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "6412.5491"
    },
    {
      "id": 34950,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "32942.0428"
    },
    {
      "id": 34952,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16592.1426"
    },
    {
      "id": 34955,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "5778",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "9637"
    },
    {
      "id": 53183,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "6158",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13794.979"
    },
    {
      "id": 53186,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "72435",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "125429"
    },
    {
      "id": 53187,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3079",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5420.2194"
    },
    {
      "id": 53189,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "7697",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31313"
    },
    {
      "id": 53197,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-03-27",
      "transaction_shares": "20033",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43628"
    },
    {
      "id": 53201,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3012",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "6412.5491"
    },
    {
      "id": 53203,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "32942.0428"
    },
    {
      "id": 53205,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16592.1426"
    },
    {
      "id": 53209,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "5778",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "9637"
    },
    {
      "id": 73932,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "6158",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13794.979"
    },
    {
      "id": 73935,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "72435",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "125429"
    },
    {
      "id": 73936,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3079",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5420.2194"
    },
    {
      "id": 73938,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "7697",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31313"
    },
    {
      "id": 73946,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-03-27",
      "transaction_shares": "20033",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43628"
    },
    {
      "id": 73950,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3012",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "6412.5491"
    },
    {
      "id": 73952,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "32942.0428"
    },
    {
      "id": 73954,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16592.1426"
    },
    {
      "id": 73958,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "5778",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "9637"
    },
    {
      "id": 96776,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "6158",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13794.979"
    },
    {
      "id": 96779,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "72435",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "125429"
    },
    {
      "id": 96780,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3079",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5420.2194"
    },
    {
      "id": 96782,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "7697",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31313"
    },
    {
      "id": 96791,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-03-27",
      "transaction_shares": "20033",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43628"
    },
    {
      "id": 96796,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3012",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "6412.5491"
    },
    {
      "id": 96798,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "32942.0428"
    },
    {
      "id": 96800,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16592.1426"
    },
    {
      "id": 96804,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "5778",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "9637"
    },
    {
      "id": 121785,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "6158",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13794.979"
    },
    {
      "id": 121788,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "72435",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "125429"
    },
    {
      "id": 121789,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3079",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5420.2194"
    },
    {
      "id": 121791,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "7697",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31313"
    },
    {
      "id": 121800,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-03-27",
      "transaction_shares": "20033",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43628"
    },
    {
      "id": 121805,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3012",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "6412.5491"
    },
    {
      "id": 121807,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "32942.0428"
    },
    {
      "id": 121809,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16592.1426"
    },
    {
      "id": 121813,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "5778",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "9637"
    },
    {
      "id": 148772,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "6158",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13794.979"
    },
    {
      "id": 148775,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "72435",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "125429"
    },
    {
      "id": 148776,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3079",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5420.2194"
    },
    {
      "id": 148778,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "7697",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31313"
    },
    {
      "id": 148787,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-03-27",
      "transaction_shares": "20033",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43628"
    },
    {
      "id": 148792,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3012",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "6412.5491"
    },
    {
      "id": 148794,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "32942.0428"
    },
    {
      "id": 148796,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16592.1426"
    },
    {
      "id": 148800,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "5778",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "9637"
    },
    {
      "id": 177874,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "6158",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13794.979"
    },
    {
      "id": 177877,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "72435",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "125429"
    },
    {
      "id": 177878,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3079",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5420.2194"
    },
    {
      "id": 177880,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "7697",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31313"
    },
    {
      "id": 177889,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-03-27",
      "transaction_shares": "20033",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43628"
    },
    {
      "id": 177894,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3012",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "6412.5491"
    },
    {
      "id": 177897,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "32942.0428"
    },
    {
      "id": 177899,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16592.1426"
    },
    {
      "id": 177903,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "5778",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "9637"
    },
    {
      "id": 209450,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "6158",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13794.979"
    },
    {
      "id": 209453,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "72435",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "125429"
    },
    {
      "id": 209454,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3079",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5420.2194"
    },
    {
      "id": 209456,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "7697",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31313"
    },
    {
      "id": 209466,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-03-27",
      "transaction_shares": "20033",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43628"
    },
    {
      "id": 209472,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3012",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "6412.5491"
    },
    {
      "id": 209475,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "32942.0428"
    },
    {
      "id": 209477,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16592.1426"
    },
    {
      "id": 209481,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "5778",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "9637"
    },
    {
      "id": 243567,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "6158",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13794.979"
    },
    {
      "id": 243570,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President and CEO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "72435",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "125429"
    },
    {
      "id": 243571,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3079",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "5420.2194"
    },
    {
      "id": 243573,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "7697",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31313"
    },
    {
      "id": 243583,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-03-27",
      "transaction_shares": "20033",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43628"
    },
    {
      "id": 243590,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-03-27",
      "transaction_shares": "3012",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "6412.5491"
    },
    {
      "id": 243593,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "32942.0428"
    },
    {
      "id": 243595,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-27",
      "transaction_shares": "11556",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16592.1426"
    },
    {
      "id": 243599,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-27",
      "transaction_shares": "5778",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "9637"
    },
    {
      "id": 8849,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-07",
      "transaction_shares": "227",
      "transaction_price": "218.45",
      "transaction_type": "S",
      "shares_after_transaction": "3859"
    },
    {
      "id": 8854,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-07",
      "transaction_shares": "2119",
      "transaction_price": "117.09",
      "transaction_type": "M",
      "shares_after_transaction": "10084.1426"
    },
    {
      "id": 20344,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-07",
      "transaction_shares": "227",
      "transaction_price": "218.45",
      "transaction_type": "S",
      "shares_after_transaction": "3859"
    },
    {
      "id": 20351,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-07",
      "transaction_shares": "2119",
      "transaction_price": "117.09",
      "transaction_type": "M",
      "shares_after_transaction": "10084.1426"
    },
    {
      "id": 34937,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-07",
      "transaction_shares": "227",
      "transaction_price": "218.45",
      "transaction_type": "S",
      "shares_after_transaction": "3859"
    },
    {
      "id": 34945,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-07",
      "transaction_shares": "2119",
      "transaction_price": "117.09",
      "transaction_type": "M",
      "shares_after_transaction": "10084.1426"
    },
    {
      "id": 53190,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-07",
      "transaction_shares": "227",
      "transaction_price": "218.45",
      "transaction_type": "S",
      "shares_after_transaction": "3859"
    },
    {
      "id": 53198,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-07",
      "transaction_shares": "2119",
      "transaction_price": "117.09",
      "transaction_type": "M",
      "shares_after_transaction": "10084.1426"
    },
    {
      "id": 73939,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-07",
      "transaction_shares": "227",
      "transaction_price": "218.45",
      "transaction_type": "S",
      "shares_after_transaction": "3859"
    },
    {
      "id": 73947,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-07",
      "transaction_shares": "2119",
      "transaction_price": "117.09",
      "transaction_type": "M",
      "shares_after_transaction": "10084.1426"
    },
    {
      "id": 96783,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-07",
      "transaction_shares": "227",
      "transaction_price": "218.45",
      "transaction_type": "S",
      "shares_after_transaction": "3859"
    },
    {
      "id": 96792,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-07",
      "transaction_shares": "2119",
      "transaction_price": "117.09",
      "transaction_type": "M",
      "shares_after_transaction": "10084.1426"
    },
    {
      "id": 121792,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-07",
      "transaction_shares": "227",
      "transaction_price": "218.45",
      "transaction_type": "S",
      "shares_after_transaction": "3859"
    },
    {
      "id": 121801,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-07",
      "transaction_shares": "2119",
      "transaction_price": "117.09",
      "transaction_type": "M",
      "shares_after_transaction": "10084.1426"
    },
    {
      "id": 148779,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-07",
      "transaction_shares": "227",
      "transaction_price": "218.45",
      "transaction_type": "S",
      "shares_after_transaction": "3859"
    },
    {
      "id": 148788,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-07",
      "transaction_shares": "2119",
      "transaction_price": "117.09",
      "transaction_type": "M",
      "shares_after_transaction": "10084.1426"
    },
    {
      "id": 177881,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-07",
      "transaction_shares": "227",
      "transaction_price": "218.45",
      "transaction_type": "S",
      "shares_after_transaction": "3859"
    },
    {
      "id": 177890,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-07",
      "transaction_shares": "2119",
      "transaction_price": "117.09",
      "transaction_type": "M",
      "shares_after_transaction": "10084.1426"
    },
    {
      "id": 209457,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-07",
      "transaction_shares": "227",
      "transaction_price": "218.45",
      "transaction_type": "S",
      "shares_after_transaction": "3859"
    },
    {
      "id": 209467,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-07",
      "transaction_shares": "2119",
      "transaction_price": "117.09",
      "transaction_type": "M",
      "shares_after_transaction": "10084.1426"
    },
    {
      "id": 243574,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-03-07",
      "transaction_shares": "227",
      "transaction_price": "218.45",
      "transaction_type": "S",
      "shares_after_transaction": "3859"
    },
    {
      "id": 243584,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-03-07",
      "transaction_shares": "2119",
      "transaction_price": "117.09",
      "transaction_type": "M",
      "shares_after_transaction": "10084.1426"
    },
    {
      "id": 1786,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-21",
      "transaction_shares": "500",
      "transaction_price": "215.4901",
      "transaction_type": "S",
      "shares_after_transaction": "3400.5491"
    },
    {
      "id": 1788,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-21",
      "transaction_shares": "14054",
      "transaction_price": "163.63",
      "transaction_type": "M",
      "shares_after_transaction": "58099"
    },
    {
      "id": 8832,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-21",
      "transaction_shares": "500",
      "transaction_price": "215.4901",
      "transaction_type": "S",
      "shares_after_transaction": "3400.5491"
    },
    {
      "id": 8834,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-21",
      "transaction_shares": "14054",
      "transaction_price": "163.63",
      "transaction_type": "M",
      "shares_after_transaction": "58099"
    },
    {
      "id": 20323,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-21",
      "transaction_shares": "500",
      "transaction_price": "215.4901",
      "transaction_type": "S",
      "shares_after_transaction": "3400.5491"
    },
    {
      "id": 20325,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-21",
      "transaction_shares": "14054",
      "transaction_price": "163.63",
      "transaction_type": "M",
      "shares_after_transaction": "58099"
    },
    {
      "id": 34915,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-21",
      "transaction_shares": "500",
      "transaction_price": "215.4901",
      "transaction_type": "S",
      "shares_after_transaction": "3400.5491"
    },
    {
      "id": 34917,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-21",
      "transaction_shares": "14054",
      "transaction_price": "163.63",
      "transaction_type": "M",
      "shares_after_transaction": "58099"
    },
    {
      "id": 53168,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-21",
      "transaction_shares": "500",
      "transaction_price": "215.4901",
      "transaction_type": "S",
      "shares_after_transaction": "3400.5491"
    },
    {
      "id": 53170,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-21",
      "transaction_shares": "14054",
      "transaction_price": "163.63",
      "transaction_type": "M",
      "shares_after_transaction": "58099"
    },
    {
      "id": 73917,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-21",
      "transaction_shares": "500",
      "transaction_price": "215.4901",
      "transaction_type": "S",
      "shares_after_transaction": "3400.5491"
    },
    {
      "id": 73919,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-21",
      "transaction_shares": "14054",
      "transaction_price": "163.63",
      "transaction_type": "M",
      "shares_after_transaction": "58099"
    },
    {
      "id": 96760,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-21",
      "transaction_shares": "500",
      "transaction_price": "215.4901",
      "transaction_type": "S",
      "shares_after_transaction": "3400.5491"
    },
    {
      "id": 96763,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-21",
      "transaction_shares": "14054",
      "transaction_price": "163.63",
      "transaction_type": "M",
      "shares_after_transaction": "58099"
    },
    {
      "id": 121769,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-21",
      "transaction_shares": "500",
      "transaction_price": "215.4901",
      "transaction_type": "S",
      "shares_after_transaction": "3400.5491"
    },
    {
      "id": 121772,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-21",
      "transaction_shares": "14054",
      "transaction_price": "163.63",
      "transaction_type": "M",
      "shares_after_transaction": "58099"
    },
    {
      "id": 148755,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-21",
      "transaction_shares": "500",
      "transaction_price": "215.4901",
      "transaction_type": "S",
      "shares_after_transaction": "3400.5491"
    },
    {
      "id": 148758,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-21",
      "transaction_shares": "14054",
      "transaction_price": "163.63",
      "transaction_type": "M",
      "shares_after_transaction": "58099"
    },
    {
      "id": 177855,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-21",
      "transaction_shares": "500",
      "transaction_price": "215.4901",
      "transaction_type": "S",
      "shares_after_transaction": "3400.5491"
    },
    {
      "id": 177858,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-21",
      "transaction_shares": "14054",
      "transaction_price": "163.63",
      "transaction_type": "M",
      "shares_after_transaction": "58099"
    },
    {
      "id": 209431,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-21",
      "transaction_shares": "500",
      "transaction_price": "215.4901",
      "transaction_type": "S",
      "shares_after_transaction": "3400.5491"
    },
    {
      "id": 209434,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-21",
      "transaction_shares": "14054",
      "transaction_price": "163.63",
      "transaction_type": "M",
      "shares_after_transaction": "58099"
    },
    {
      "id": 243548,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-21",
      "transaction_shares": "500",
      "transaction_price": "215.4901",
      "transaction_type": "S",
      "shares_after_transaction": "3400.5491"
    },
    {
      "id": 243551,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-21",
      "transaction_shares": "14054",
      "transaction_price": "163.63",
      "transaction_type": "M",
      "shares_after_transaction": "58099"
    },
    {
      "id": 1773,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-13",
      "transaction_shares": "237",
      "transaction_price": "226.45",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 8819,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-13",
      "transaction_shares": "237",
      "transaction_price": "226.45",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 20308,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-13",
      "transaction_shares": "237",
      "transaction_price": "226.45",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 34899,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-13",
      "transaction_shares": "237",
      "transaction_price": "226.45",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 53152,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-13",
      "transaction_shares": "237",
      "transaction_price": "226.45",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 73901,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-13",
      "transaction_shares": "237",
      "transaction_price": "226.45",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 96743,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-13",
      "transaction_shares": "237",
      "transaction_price": "226.45",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 121752,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-13",
      "transaction_shares": "237",
      "transaction_price": "226.45",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 148738,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-13",
      "transaction_shares": "237",
      "transaction_price": "226.45",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 177837,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-13",
      "transaction_shares": "237",
      "transaction_price": "226.45",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 209412,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-13",
      "transaction_shares": "237",
      "transaction_price": "226.45",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 243529,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-13",
      "transaction_shares": "237",
      "transaction_price": "226.45",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 1780,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-11",
      "transaction_shares": "807",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "44260"
    },
    {
      "id": 1782,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8091.1426"
    },
    {
      "id": 1787,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21523.0428"
    },
    {
      "id": 1801,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "123",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2384.2194"
    },
    {
      "id": 1802,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4152"
    },
    {
      "id": 1803,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "2964",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "54225"
    },
    {
      "id": 1809,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23703"
    },
    {
      "id": 1812,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3959.5491"
    },
    {
      "id": 1813,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7960.979"
    },
    {
      "id": 8826,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-11",
      "transaction_shares": "807",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "44260"
    },
    {
      "id": 8828,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8091.1426"
    },
    {
      "id": 8833,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21523.0428"
    },
    {
      "id": 8847,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "123",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2384.2194"
    },
    {
      "id": 8848,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4152"
    },
    {
      "id": 8850,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "2964",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "54225"
    },
    {
      "id": 8857,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23703"
    },
    {
      "id": 8860,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3959.5491"
    },
    {
      "id": 8861,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7960.979"
    },
    {
      "id": 20315,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-11",
      "transaction_shares": "807",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "44260"
    },
    {
      "id": 20317,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8091.1426"
    },
    {
      "id": 20324,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21523.0428"
    },
    {
      "id": 20339,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "123",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2384.2194"
    },
    {
      "id": 20342,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4152"
    },
    {
      "id": 20345,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "2964",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "54225"
    },
    {
      "id": 20355,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23703"
    },
    {
      "id": 20361,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3959.5491"
    },
    {
      "id": 20362,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7960.979"
    },
    {
      "id": 34906,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-11",
      "transaction_shares": "807",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "44260"
    },
    {
      "id": 34909,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8091.1426"
    },
    {
      "id": 34916,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21523.0428"
    },
    {
      "id": 34932,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "123",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2384.2194"
    },
    {
      "id": 34935,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4152"
    },
    {
      "id": 34938,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "2964",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "54225"
    },
    {
      "id": 34949,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23703"
    },
    {
      "id": 34956,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3959.5491"
    },
    {
      "id": 34957,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7960.979"
    },
    {
      "id": 53159,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-11",
      "transaction_shares": "807",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "44260"
    },
    {
      "id": 53162,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8091.1426"
    },
    {
      "id": 53169,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21523.0428"
    },
    {
      "id": 53185,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "123",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2384.2194"
    },
    {
      "id": 53188,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4152"
    },
    {
      "id": 53191,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "2964",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "54225"
    },
    {
      "id": 53202,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23703"
    },
    {
      "id": 53210,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3959.5491"
    },
    {
      "id": 53211,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7960.979"
    },
    {
      "id": 73908,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-11",
      "transaction_shares": "807",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "44260"
    },
    {
      "id": 73911,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8091.1426"
    },
    {
      "id": 73918,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21523.0428"
    },
    {
      "id": 73934,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "123",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2384.2194"
    },
    {
      "id": 73937,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4152"
    },
    {
      "id": 73940,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "2964",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "54225"
    },
    {
      "id": 73951,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23703"
    },
    {
      "id": 73959,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3959.5491"
    },
    {
      "id": 73960,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7960.979"
    },
    {
      "id": 96750,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-11",
      "transaction_shares": "807",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "44260"
    },
    {
      "id": 96754,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8091.1426"
    },
    {
      "id": 96762,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21523.0428"
    },
    {
      "id": 96778,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "123",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2384.2194"
    },
    {
      "id": 96781,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4152"
    },
    {
      "id": 96784,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "2964",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "54225"
    },
    {
      "id": 96797,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23703"
    },
    {
      "id": 96805,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3959.5491"
    },
    {
      "id": 96806,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7960.979"
    },
    {
      "id": 121759,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-11",
      "transaction_shares": "807",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "44260"
    },
    {
      "id": 121763,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8091.1426"
    },
    {
      "id": 121771,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21523.0428"
    },
    {
      "id": 121787,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "123",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2384.2194"
    },
    {
      "id": 121790,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4152"
    },
    {
      "id": 121793,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "2964",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "54225"
    },
    {
      "id": 121806,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23703"
    },
    {
      "id": 121814,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3959.5491"
    },
    {
      "id": 121815,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7960.979"
    },
    {
      "id": 148745,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-11",
      "transaction_shares": "807",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "44260"
    },
    {
      "id": 148749,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8091.1426"
    },
    {
      "id": 148757,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21523.0428"
    },
    {
      "id": 148774,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "123",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2384.2194"
    },
    {
      "id": 148777,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4152"
    },
    {
      "id": 148780,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "2964",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "54225"
    },
    {
      "id": 148793,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23703"
    },
    {
      "id": 148801,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3959.5491"
    },
    {
      "id": 148802,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7960.979"
    },
    {
      "id": 177844,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-11",
      "transaction_shares": "807",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "44260"
    },
    {
      "id": 177848,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8091.1426"
    },
    {
      "id": 177857,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21523.0428"
    },
    {
      "id": 177876,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "123",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2384.2194"
    },
    {
      "id": 177879,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4152"
    },
    {
      "id": 177882,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "2964",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "54225"
    },
    {
      "id": 177895,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23703"
    },
    {
      "id": 177905,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3959.5491"
    },
    {
      "id": 177906,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7960.979"
    },
    {
      "id": 209419,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-11",
      "transaction_shares": "807",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "44260"
    },
    {
      "id": 209423,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8091.1426"
    },
    {
      "id": 209433,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21523.0428"
    },
    {
      "id": 209452,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "123",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2384.2194"
    },
    {
      "id": 209455,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4152"
    },
    {
      "id": 209459,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "2964",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "54225"
    },
    {
      "id": 209473,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23703"
    },
    {
      "id": 209483,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3959.5491"
    },
    {
      "id": 209484,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7960.979"
    },
    {
      "id": 243536,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-11",
      "transaction_shares": "807",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "44260"
    },
    {
      "id": 243540,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8091.1426"
    },
    {
      "id": 243550,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21523.0428"
    },
    {
      "id": 243569,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "123",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2384.2194"
    },
    {
      "id": 243572,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4152"
    },
    {
      "id": 243576,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "2964",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "54225"
    },
    {
      "id": 243591,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23703"
    },
    {
      "id": 243601,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3959.5491"
    },
    {
      "id": 243602,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7960.979"
    },
    {
      "id": 1805,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "259",
      "transaction_price": "222.06",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 8852,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "259",
      "transaction_price": "222.06",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 20348,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "259",
      "transaction_price": "222.06",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 34942,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "259",
      "transaction_price": "222.06",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 53195,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "259",
      "transaction_price": "222.06",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 73944,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "259",
      "transaction_price": "222.06",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 96788,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "259",
      "transaction_price": "222.06",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 121797,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "259",
      "transaction_price": "222.06",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 148784,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "259",
      "transaction_price": "222.06",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 177886,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "259",
      "transaction_price": "222.06",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 209463,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "259",
      "transaction_price": "222.06",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 243580,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "259",
      "transaction_price": "222.06",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 1770,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23473"
    },
    {
      "id": 1771,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3619"
    },
    {
      "id": 1772,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8534"
    },
    {
      "id": 1776,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16222"
    },
    {
      "id": 1777,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21143.0428"
    },
    {
      "id": 1778,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-07",
      "transaction_shares": "885",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43689"
    },
    {
      "id": 1779,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7638.1426"
    },
    {
      "id": 1783,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "134",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2307.2194"
    },
    {
      "id": 1785,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3739.5491"
    },
    {
      "id": 1789,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4024"
    },
    {
      "id": 1790,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2292"
    },
    {
      "id": 1792,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7989.979"
    },
    {
      "id": 1794,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17876"
    },
    {
      "id": 1796,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "GRAHAM ANITA Z",
      "reporting_owner_cik": "0001206814",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "369",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "399"
    },
    {
      "id": 1798,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8712"
    },
    {
      "id": 1799,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "3250",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "52410"
    },
    {
      "id": 1800,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11943"
    },
    {
      "id": 1804,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8120"
    },
    {
      "id": 1807,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11898"
    },
    {
      "id": 1808,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "346"
    },
    {
      "id": 1810,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kliphouse Kirsten Marie",
      "reporting_owner_cik": "0001948684",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1319"
    },
    {
      "id": 8816,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23473"
    },
    {
      "id": 8817,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3619"
    },
    {
      "id": 8818,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8534"
    },
    {
      "id": 8822,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16222"
    },
    {
      "id": 8823,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21143.0428"
    },
    {
      "id": 8824,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-07",
      "transaction_shares": "885",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43689"
    },
    {
      "id": 8825,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7638.1426"
    },
    {
      "id": 8829,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "134",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2307.2194"
    },
    {
      "id": 8831,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3739.5491"
    },
    {
      "id": 8835,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4024"
    },
    {
      "id": 8836,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2292"
    },
    {
      "id": 8838,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7989.979"
    },
    {
      "id": 8840,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17876"
    },
    {
      "id": 8842,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "GRAHAM ANITA Z",
      "reporting_owner_cik": "0001206814",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "369",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "399"
    },
    {
      "id": 8844,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8712"
    },
    {
      "id": 8845,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "3250",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "52410"
    },
    {
      "id": 8846,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11943"
    },
    {
      "id": 8851,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8120"
    },
    {
      "id": 8855,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11898"
    },
    {
      "id": 8856,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "346"
    },
    {
      "id": 8858,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kliphouse Kirsten Marie",
      "reporting_owner_cik": "0001948684",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1319"
    },
    {
      "id": 20304,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23473"
    },
    {
      "id": 20305,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3619"
    },
    {
      "id": 20306,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8534"
    },
    {
      "id": 20311,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16222"
    },
    {
      "id": 20312,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21143.0428"
    },
    {
      "id": 20313,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-07",
      "transaction_shares": "885",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43689"
    },
    {
      "id": 20314,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7638.1426"
    },
    {
      "id": 20318,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "134",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2307.2194"
    },
    {
      "id": 20322,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3739.5491"
    },
    {
      "id": 20326,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4024"
    },
    {
      "id": 20327,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2292"
    },
    {
      "id": 20329,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7989.979"
    },
    {
      "id": 20331,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17876"
    },
    {
      "id": 20333,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "GRAHAM ANITA Z",
      "reporting_owner_cik": "0001206814",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "369",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "399"
    },
    {
      "id": 20335,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8712"
    },
    {
      "id": 20336,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "3250",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "52410"
    },
    {
      "id": 20338,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11943"
    },
    {
      "id": 20347,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8120"
    },
    {
      "id": 20352,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11898"
    },
    {
      "id": 20353,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "346"
    },
    {
      "id": 20357,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kliphouse Kirsten Marie",
      "reporting_owner_cik": "0001948684",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1319"
    },
    {
      "id": 34895,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23473"
    },
    {
      "id": 34896,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3619"
    },
    {
      "id": 34897,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8534"
    },
    {
      "id": 34902,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16222"
    },
    {
      "id": 34903,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21143.0428"
    },
    {
      "id": 34904,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-07",
      "transaction_shares": "885",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43689"
    },
    {
      "id": 34905,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7638.1426"
    },
    {
      "id": 34910,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "134",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2307.2194"
    },
    {
      "id": 34914,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3739.5491"
    },
    {
      "id": 34918,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4024"
    },
    {
      "id": 34919,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2292"
    },
    {
      "id": 34921,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7989.979"
    },
    {
      "id": 34923,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17876"
    },
    {
      "id": 34926,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "GRAHAM ANITA Z",
      "reporting_owner_cik": "0001206814",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "369",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "399"
    },
    {
      "id": 34928,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8712"
    },
    {
      "id": 34929,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "3250",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "52410"
    },
    {
      "id": 34931,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11943"
    },
    {
      "id": 34941,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8120"
    },
    {
      "id": 34946,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11898"
    },
    {
      "id": 34947,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "346"
    },
    {
      "id": 34951,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kliphouse Kirsten Marie",
      "reporting_owner_cik": "0001948684",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1319"
    },
    {
      "id": 53148,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23473"
    },
    {
      "id": 53149,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3619"
    },
    {
      "id": 53150,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8534"
    },
    {
      "id": 53155,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16222"
    },
    {
      "id": 53156,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21143.0428"
    },
    {
      "id": 53157,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-07",
      "transaction_shares": "885",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43689"
    },
    {
      "id": 53158,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7638.1426"
    },
    {
      "id": 53163,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "134",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2307.2194"
    },
    {
      "id": 53167,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3739.5491"
    },
    {
      "id": 53171,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4024"
    },
    {
      "id": 53172,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2292"
    },
    {
      "id": 53174,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7989.979"
    },
    {
      "id": 53176,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17876"
    },
    {
      "id": 53179,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "GRAHAM ANITA Z",
      "reporting_owner_cik": "0001206814",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "369",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "399"
    },
    {
      "id": 53181,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8712"
    },
    {
      "id": 53182,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "3250",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "52410"
    },
    {
      "id": 53184,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11943"
    },
    {
      "id": 53194,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8120"
    },
    {
      "id": 53199,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11898"
    },
    {
      "id": 53200,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "346"
    },
    {
      "id": 53204,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kliphouse Kirsten Marie",
      "reporting_owner_cik": "0001948684",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1319"
    },
    {
      "id": 73897,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23473"
    },
    {
      "id": 73898,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3619"
    },
    {
      "id": 73899,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8534"
    },
    {
      "id": 73904,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16222"
    },
    {
      "id": 73905,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21143.0428"
    },
    {
      "id": 73906,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-07",
      "transaction_shares": "885",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43689"
    },
    {
      "id": 73907,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7638.1426"
    },
    {
      "id": 73912,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "134",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2307.2194"
    },
    {
      "id": 73916,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3739.5491"
    },
    {
      "id": 73920,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4024"
    },
    {
      "id": 73921,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2292"
    },
    {
      "id": 73923,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7989.979"
    },
    {
      "id": 73925,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17876"
    },
    {
      "id": 73928,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "GRAHAM ANITA Z",
      "reporting_owner_cik": "0001206814",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "369",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "399"
    },
    {
      "id": 73930,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8712"
    },
    {
      "id": 73931,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "3250",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "52410"
    },
    {
      "id": 73933,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11943"
    },
    {
      "id": 73943,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8120"
    },
    {
      "id": 73948,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11898"
    },
    {
      "id": 73949,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "346"
    },
    {
      "id": 73953,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kliphouse Kirsten Marie",
      "reporting_owner_cik": "0001948684",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1319"
    },
    {
      "id": 96739,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23473"
    },
    {
      "id": 96740,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3619"
    },
    {
      "id": 96741,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8534"
    },
    {
      "id": 96746,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16222"
    },
    {
      "id": 96747,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21143.0428"
    },
    {
      "id": 96748,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-07",
      "transaction_shares": "885",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43689"
    },
    {
      "id": 96749,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7638.1426"
    },
    {
      "id": 96755,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "134",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2307.2194"
    },
    {
      "id": 96759,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3739.5491"
    },
    {
      "id": 96764,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4024"
    },
    {
      "id": 96765,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2292"
    },
    {
      "id": 96767,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7989.979"
    },
    {
      "id": 96769,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17876"
    },
    {
      "id": 96772,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "GRAHAM ANITA Z",
      "reporting_owner_cik": "0001206814",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "369",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "399"
    },
    {
      "id": 96774,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8712"
    },
    {
      "id": 96775,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "3250",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "52410"
    },
    {
      "id": 96777,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11943"
    },
    {
      "id": 96787,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8120"
    },
    {
      "id": 96793,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11898"
    },
    {
      "id": 96795,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "346"
    },
    {
      "id": 96799,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kliphouse Kirsten Marie",
      "reporting_owner_cik": "0001948684",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1319"
    },
    {
      "id": 121748,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23473"
    },
    {
      "id": 121749,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3619"
    },
    {
      "id": 121750,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8534"
    },
    {
      "id": 121755,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16222"
    },
    {
      "id": 121756,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21143.0428"
    },
    {
      "id": 121757,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-07",
      "transaction_shares": "885",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43689"
    },
    {
      "id": 121758,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7638.1426"
    },
    {
      "id": 121764,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "134",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2307.2194"
    },
    {
      "id": 121768,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3739.5491"
    },
    {
      "id": 121773,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4024"
    },
    {
      "id": 121774,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2292"
    },
    {
      "id": 121776,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7989.979"
    },
    {
      "id": 121778,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17876"
    },
    {
      "id": 121781,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "GRAHAM ANITA Z",
      "reporting_owner_cik": "0001206814",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "369",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "399"
    },
    {
      "id": 121783,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8712"
    },
    {
      "id": 121784,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "3250",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "52410"
    },
    {
      "id": 121786,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11943"
    },
    {
      "id": 121796,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8120"
    },
    {
      "id": 121802,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11898"
    },
    {
      "id": 121804,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "346"
    },
    {
      "id": 121808,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kliphouse Kirsten Marie",
      "reporting_owner_cik": "0001948684",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1319"
    },
    {
      "id": 148734,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23473"
    },
    {
      "id": 148735,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3619"
    },
    {
      "id": 148736,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8534"
    },
    {
      "id": 148741,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16222"
    },
    {
      "id": 148742,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21143.0428"
    },
    {
      "id": 148743,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-07",
      "transaction_shares": "885",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43689"
    },
    {
      "id": 148744,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7638.1426"
    },
    {
      "id": 148750,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "134",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2307.2194"
    },
    {
      "id": 148754,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3739.5491"
    },
    {
      "id": 148759,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4024"
    },
    {
      "id": 148761,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2292"
    },
    {
      "id": 148763,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7989.979"
    },
    {
      "id": 148765,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17876"
    },
    {
      "id": 148768,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "GRAHAM ANITA Z",
      "reporting_owner_cik": "0001206814",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "369",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "399"
    },
    {
      "id": 148770,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8712"
    },
    {
      "id": 148771,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "3250",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "52410"
    },
    {
      "id": 148773,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11943"
    },
    {
      "id": 148783,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8120"
    },
    {
      "id": 148789,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11898"
    },
    {
      "id": 148791,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "346"
    },
    {
      "id": 148795,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kliphouse Kirsten Marie",
      "reporting_owner_cik": "0001948684",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1319"
    },
    {
      "id": 177833,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23473"
    },
    {
      "id": 177834,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3619"
    },
    {
      "id": 177835,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8534"
    },
    {
      "id": 177840,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16222"
    },
    {
      "id": 177841,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21143.0428"
    },
    {
      "id": 177842,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-07",
      "transaction_shares": "885",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43689"
    },
    {
      "id": 177843,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7638.1426"
    },
    {
      "id": 177849,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "134",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2307.2194"
    },
    {
      "id": 177854,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3739.5491"
    },
    {
      "id": 177859,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4024"
    },
    {
      "id": 177862,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2292"
    },
    {
      "id": 177864,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7989.979"
    },
    {
      "id": 177867,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17876"
    },
    {
      "id": 177870,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "GRAHAM ANITA Z",
      "reporting_owner_cik": "0001206814",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "369",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "399"
    },
    {
      "id": 177872,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8712"
    },
    {
      "id": 177873,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "3250",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "52410"
    },
    {
      "id": 177875,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11943"
    },
    {
      "id": 177885,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8120"
    },
    {
      "id": 177891,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11898"
    },
    {
      "id": 177893,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "346"
    },
    {
      "id": 177898,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kliphouse Kirsten Marie",
      "reporting_owner_cik": "0001948684",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1319"
    },
    {
      "id": 209408,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23473"
    },
    {
      "id": 209409,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3619"
    },
    {
      "id": 209410,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8534"
    },
    {
      "id": 209415,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16222"
    },
    {
      "id": 209416,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21143.0428"
    },
    {
      "id": 209417,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-07",
      "transaction_shares": "885",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43689"
    },
    {
      "id": 209418,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7638.1426"
    },
    {
      "id": 209424,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "134",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2307.2194"
    },
    {
      "id": 209430,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3739.5491"
    },
    {
      "id": 209435,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4024"
    },
    {
      "id": 209438,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2292"
    },
    {
      "id": 209440,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7989.979"
    },
    {
      "id": 209443,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17876"
    },
    {
      "id": 209446,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "GRAHAM ANITA Z",
      "reporting_owner_cik": "0001206814",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "369",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "399"
    },
    {
      "id": 209448,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8712"
    },
    {
      "id": 209449,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "3250",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "52410"
    },
    {
      "id": 209451,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11943"
    },
    {
      "id": 209462,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8120"
    },
    {
      "id": 209468,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11898"
    },
    {
      "id": 209471,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "346"
    },
    {
      "id": 209476,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kliphouse Kirsten Marie",
      "reporting_owner_cik": "0001948684",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1319"
    },
    {
      "id": 243525,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23473"
    },
    {
      "id": 243526,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3619"
    },
    {
      "id": 243527,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8534"
    },
    {
      "id": 243532,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16222"
    },
    {
      "id": 243533,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21143.0428"
    },
    {
      "id": 243534,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-07",
      "transaction_shares": "885",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43689"
    },
    {
      "id": 243535,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7638.1426"
    },
    {
      "id": 243541,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "134",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2307.2194"
    },
    {
      "id": 243547,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3739.5491"
    },
    {
      "id": 243552,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4024"
    },
    {
      "id": 243555,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2292"
    },
    {
      "id": 243557,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7989.979"
    },
    {
      "id": 243560,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17876"
    },
    {
      "id": 243563,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "GRAHAM ANITA Z",
      "reporting_owner_cik": "0001206814",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "369",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "399"
    },
    {
      "id": 243565,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8712"
    },
    {
      "id": 243566,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "3250",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "52410"
    },
    {
      "id": 243568,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11943"
    },
    {
      "id": 243579,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8120"
    },
    {
      "id": 243585,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11898"
    },
    {
      "id": 243588,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "346"
    },
    {
      "id": 243594,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kliphouse Kirsten Marie",
      "reporting_owner_cik": "0001948684",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1319"
    },
    {
      "id": 1774,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20792.0428"
    },
    {
      "id": 1775,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "131",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2218.2194"
    },
    {
      "id": 1781,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-02",
      "transaction_shares": "856",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43032"
    },
    {
      "id": 1784,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3600.5491"
    },
    {
      "id": 1791,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "3094",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "49982"
    },
    {
      "id": 1793,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "264",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7900.979"
    },
    {
      "id": 1795,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3880"
    },
    {
      "id": 1797,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "331",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23209"
    },
    {
      "id": 1806,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7253.1426"
    },
    {
      "id": 8820,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20792.0428"
    },
    {
      "id": 8821,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "131",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2218.2194"
    },
    {
      "id": 8827,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-02",
      "transaction_shares": "856",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43032"
    },
    {
      "id": 8830,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3600.5491"
    },
    {
      "id": 8837,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "3094",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "49982"
    },
    {
      "id": 8839,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "264",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7900.979"
    },
    {
      "id": 8841,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3880"
    },
    {
      "id": 8843,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "331",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23209"
    },
    {
      "id": 8853,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7253.1426"
    },
    {
      "id": 20309,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20792.0428"
    },
    {
      "id": 20310,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "131",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2218.2194"
    },
    {
      "id": 20316,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-02",
      "transaction_shares": "856",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43032"
    },
    {
      "id": 20320,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3600.5491"
    },
    {
      "id": 20328,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "3094",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "49982"
    },
    {
      "id": 20330,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "264",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7900.979"
    },
    {
      "id": 20332,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3880"
    },
    {
      "id": 20334,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "331",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23209"
    },
    {
      "id": 20349,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7253.1426"
    },
    {
      "id": 34900,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20792.0428"
    },
    {
      "id": 34901,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "131",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2218.2194"
    },
    {
      "id": 34907,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-02",
      "transaction_shares": "856",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43032"
    },
    {
      "id": 34912,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3600.5491"
    },
    {
      "id": 34920,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "3094",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "49982"
    },
    {
      "id": 34922,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "264",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7900.979"
    },
    {
      "id": 34925,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3880"
    },
    {
      "id": 34927,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "331",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23209"
    },
    {
      "id": 34943,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7253.1426"
    },
    {
      "id": 53153,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20792.0428"
    },
    {
      "id": 53154,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "131",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2218.2194"
    },
    {
      "id": 53160,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-02",
      "transaction_shares": "856",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43032"
    },
    {
      "id": 53165,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3600.5491"
    },
    {
      "id": 53173,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "3094",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "49982"
    },
    {
      "id": 53175,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "264",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7900.979"
    },
    {
      "id": 53178,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3880"
    },
    {
      "id": 53180,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "331",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23209"
    },
    {
      "id": 53196,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7253.1426"
    },
    {
      "id": 73902,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20792.0428"
    },
    {
      "id": 73903,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "131",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2218.2194"
    },
    {
      "id": 73909,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-02",
      "transaction_shares": "856",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43032"
    },
    {
      "id": 73914,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3600.5491"
    },
    {
      "id": 73922,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "3094",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "49982"
    },
    {
      "id": 73924,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "264",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7900.979"
    },
    {
      "id": 73927,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3880"
    },
    {
      "id": 73929,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "331",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23209"
    },
    {
      "id": 73945,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7253.1426"
    },
    {
      "id": 96744,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20792.0428"
    },
    {
      "id": 96745,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "131",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2218.2194"
    },
    {
      "id": 96752,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-02",
      "transaction_shares": "856",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43032"
    },
    {
      "id": 96757,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3600.5491"
    },
    {
      "id": 96766,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "3094",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "49982"
    },
    {
      "id": 96768,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "264",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7900.979"
    },
    {
      "id": 96771,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3880"
    },
    {
      "id": 96773,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "331",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23209"
    },
    {
      "id": 96790,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7253.1426"
    },
    {
      "id": 121753,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20792.0428"
    },
    {
      "id": 121754,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "131",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2218.2194"
    },
    {
      "id": 121761,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-02",
      "transaction_shares": "856",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43032"
    },
    {
      "id": 121766,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3600.5491"
    },
    {
      "id": 121775,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "3094",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "49982"
    },
    {
      "id": 121777,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "264",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7900.979"
    },
    {
      "id": 121780,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3880"
    },
    {
      "id": 121782,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "331",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23209"
    },
    {
      "id": 121799,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7253.1426"
    },
    {
      "id": 148739,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20792.0428"
    },
    {
      "id": 148740,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "131",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2218.2194"
    },
    {
      "id": 148747,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-02",
      "transaction_shares": "856",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43032"
    },
    {
      "id": 148752,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3600.5491"
    },
    {
      "id": 148762,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "3094",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "49982"
    },
    {
      "id": 148764,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "264",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7900.979"
    },
    {
      "id": 148767,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3880"
    },
    {
      "id": 148769,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "331",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23209"
    },
    {
      "id": 148786,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7253.1426"
    },
    {
      "id": 177838,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20792.0428"
    },
    {
      "id": 177839,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "131",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2218.2194"
    },
    {
      "id": 177846,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-02",
      "transaction_shares": "856",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43032"
    },
    {
      "id": 177852,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3600.5491"
    },
    {
      "id": 177863,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "3094",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "49982"
    },
    {
      "id": 177865,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "264",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7900.979"
    },
    {
      "id": 177869,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3880"
    },
    {
      "id": 177871,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "331",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23209"
    },
    {
      "id": 177888,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7253.1426"
    },
    {
      "id": 209413,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20792.0428"
    },
    {
      "id": 209414,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "131",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2218.2194"
    },
    {
      "id": 209421,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-02",
      "transaction_shares": "856",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43032"
    },
    {
      "id": 209428,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3600.5491"
    },
    {
      "id": 209439,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "3094",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "49982"
    },
    {
      "id": 209441,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "264",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7900.979"
    },
    {
      "id": 209445,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3880"
    },
    {
      "id": 209447,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "331",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23209"
    },
    {
      "id": 209465,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7253.1426"
    },
    {
      "id": 243530,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20792.0428"
    },
    {
      "id": 243531,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "131",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2218.2194"
    },
    {
      "id": 243538,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-02",
      "transaction_shares": "856",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43032"
    },
    {
      "id": 243545,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3600.5491"
    },
    {
      "id": 243556,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "3094",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "49982"
    },
    {
      "id": 243558,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "264",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7900.979"
    },
    {
      "id": 243562,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3880"
    },
    {
      "id": 243564,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "331",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23209"
    },
    {
      "id": 243582,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7253.1426"
    }
  ]
}